Article
Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment.
PloS one - 1 Jan 2016
Kjær Lasse, Cordua Sabrina, Holmström Morten O, Thomassen Mads, Kruse Torben A, Pallisgaard Niels, Larsen Thomas S, de Stricker Karin, Skov Vibe, Hasselbalch Hans C
Abstract excerpt
Discovery of somatic mutations in the calreticulin gene (CALR) has identified a subgroup of Philadelphia-negative chronic myeloproliferative neoplasms (MPN) with separate haematological characteristics and prognosis. CALR mutations serve as novel markers both of diagnostic value and as targets for monitoring molecular responses during therapy. Interferon-α (IFN) selectively targets the malignant clone in a subset...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
